Report Detail
(Post-pandemic Era)-Global Emergency Contraceptives Market Segment Research Report 2021
- RnM4303759 |
- 07 August, 2021 |
- Global |
- 103 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic Prospects: Growth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Emergency Contraceptives market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to XYZResearch analysis, The segment in Emergency Contraceptives market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Emergency Contraceptives production is XX (K Units). US market value in 2021 is about USD XX billion, and US Emergency Contraceptives production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Emergency Contraceptives production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Emergency Contraceptives Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Emergency Contraceptives Market?
Genetics
Teva Pharmaceutical
Uniprix
Gavis Pharmaceuticals
HRA Pharma
Mankind Pharma
...
Major Type of Emergency Contraceptives Covered in XYZResearch report:
Combined estrogen and progestin pills
Progestin-only (as Levonorgestrel) pills
Antiprogestin (as mifepristone) pills
Ulipristal acetate pills
Application Segments Covered in XYZResearch Market
Hospital pharmacies
Retail pharmacies
Online pharmacies
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Emergency Contraceptives Market Segment Research Report 2021
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Emergency Contraceptives Market by Value
- 2.2.1 Global Emergency Contraceptives Revenue by Type
- 2.2.2 Global Emergency Contraceptives Market by Value (%)
- 2.3 Global Emergency Contraceptives Market by Production
- 2.3.1 Global Emergency Contraceptives Production by Type
- 2.3.2 Global Emergency Contraceptives Market by Production (%)
3. The Major Driver of Emergency Contraceptives Industry
- 3.1 Historical & Forecast Global Emergency Contraceptives Demand
- 3.2 Largest Application for Emergency Contraceptives (2017-2027)
- 3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Emergency Contraceptives Market
- 4.1 Regional Market Size in Terms of Production & Demand (2021)
- 4.2 Regional Market Share in Terms of Revenue (2019-2027)
- 4.3 Concentration Ratio (CR5& CR10) of Emergency Contraceptives Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Emergency Contraceptives Production, Demand (2017-2027)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Emergency Contraceptives Production, Demand (2017-2027)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Emergency Contraceptives Production, Demand (2017-2027)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Emergency Contraceptives Production, Demand (2017-2027)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Emergency Contraceptives Production, Demand (2017-2027)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Emergency Contraceptives Production, Demand (2017-2027)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Emergency Contraceptives Production, Demand (2017-2027)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
- 11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Emergency Contraceptives Average Price Trend
- 12.1 Market Price for Each Type of Emergency Contraceptives in US (2017-2021)
- 12.2 Market Price for Each Type of Emergency Contraceptives in Europe (2017-2021)
- 12.3 Market Price for Each Type of Emergency Contraceptives in China (2017-2021)
- 12.4 Market Price for Each Type of Emergency Contraceptives in Japan (2017-2021)
- 12.5 Market Price for Each Type of Emergency Contraceptives in India (2017-2021)
- 12.6 Market Price for Each Type of Emergency Contraceptives in Korea (2017-2021)
- 12.7 Market Price for Each Type of Emergency Contraceptives in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Emergency Contraceptives Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Technology Trends of Emergency Contraceptives
14. Emergency Contraceptives Competitive Landscape
- 14.1 Genetics
- 14.1.1 Genetics Company Profiles
- 14.1.2 Genetics Product Introduction
- 14.1.3 Genetics Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.1.4 Strategic initiatives
- 14.2 Teva Pharmaceutical
- 14.2.1 Teva Pharmaceutical Company Profiles
- 14.2.2 Teva Pharmaceutical Product Introduction
- 14.2.3 Teva Pharmaceutical Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.2.4 Strategic initiatives
- 14.3 Uniprix
- 14.3.1 Uniprix Company Profiles
- 14.3.2 Uniprix Product Introduction
- 14.3.3 Uniprix Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.3.4 Strategic initiatives
- 14.4 Gavis Pharmaceuticals
- 14.4.1 Gavis Pharmaceuticals Company Profiles
- 14.4.2 Gavis Pharmaceuticals Product Introduction
- 14.4.3 Gavis Pharmaceuticals Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.4.4 Strategic initiatives
- 14.5 HRA Pharma
- 14.5.1 HRA Pharma Company Profiles
- 14.5.2 HRA Pharma Product Introduction
- 14.5.3 HRA Pharma Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.5.4 Strategic initiatives
- 14.6 Mankind Pharma
- 14.6.1 Mankind Pharma Company Profiles
- 14.6.2 Mankind Pharma Product Introduction
- 14.6.3 Mankind Pharma Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.6.4 Strategic initiatives
- 14.7 ...
- 14.7.1 ... Company Profiles
- 14.7.2 ... Product Introduction
- 14.7.3 ... Emergency Contraceptives Sales, Revenue (2017-2021)
- 14.7.4 Strategic initiatives
15. Conclusion
Summary:
Get latest Market Research Reports on Emergency Contraceptives. Industry analysis & Market Report on Emergency Contraceptives is a syndicated market report, published as (Post-pandemic Era)-Global Emergency Contraceptives Market Segment Research Report 2021. It is complete Research Study and Industry Analysis of Emergency Contraceptives market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
